Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20355)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR50 | GRmax | GR_AOC | GEC50 | GRinf | GR Hill Coefficient | GR r2 | pval_GR |
|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-157 | Alvocidib | 0.152222738 | -0.8658 | 0.2879 | 0.2794 | -1.0000 | 1.8087 | 0.9385 | 7.77e-16 |
| MDA-MB-157 | MK 1775 | -inf | -0.8758 | ||||||
| HCC1428 | THZ1 | 0.011292388 | -0.8773 | 0.6550 | 0.0212 | -0.7576 | 1.4635 | 0.8598 | 2.16e-11 |
| HCC70 | THZ1 | -inf | -0.8868 | ||||||
| HCC1428 | THZ531 | 0.034802646 | -0.8953 | 0.6552 | 0.0565 | -0.7360 | 1.8647 | 0.7050 | 2.36e-07 |
| MDA-MB-157 | THZ1 | 0.032181836 | -0.8998 | 0.5842 | 0.0485 | -0.8227 | 2.3777 | 0.9766 | 1.11e-16 |
| MDA-MB-134-VI | LY3023414 | 2.28e-05 | -0.9131 | 1.4118 | 0.0019 | -1.0000 | 0.2471 | 0.8907 | 9.62e-13 |
| HCC1500 | AZD6738 | -inf | -0.9469 | ||||||
| HCC1500 | MK 1775 | -inf | -0.9646 | ||||||
| HCC1500 | Senexin B | -inf | -0.9794 | ||||||
| MDA-MB-361 | LY3023414 | 1.3e-05 | -0.9848 | 1.4263 | 0.0014 | -1.0000 | 0.2362 | 0.9070 | 1.28e-13 |
| HCC1500 | RO-3306 | -inf | -0.9896 | ||||||
| HCC1500 | LY3023414 | 2.44e-06 | -0.9965 | 1.9835 | 0.0000 | -0.9955 | 0.7773 | 0.6628 | 1.25e-06 |
| HCC1500 | Alvocidib | -inf | -0.9990 | ||||||
| HCC1500 | THZ531 | -inf | -0.9990 | ||||||
| HCC1500 | AZD2014 | 1.37e-05 | -0.9997 | 1.9963 | 0.0000 | -0.9980 | 1.4781 | 0.6747 | 8.02e-07 |
| HCC1500 | THZ1 | -inf | -0.9999 | ||||||
| Hs 578T | BMS-265246 | -inf | |||||||
| MDA-MB-436 | AZD6738 | -inf |